These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8902156)

  • 1. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
    Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
    Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis.
    Donner MG; Parhofer KG; Richter WO; Schwandt P
    Metabolism; 1999 Jul; 48(7):881-6. PubMed ID: 10421230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2alpha.
    Oguogho A; Ferlitsch A; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2000 Apr; 62(4):209-16. PubMed ID: 10882184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term effects of low-density lipoprotein (LDL)-apheresis on oxidative damage to LDL and reducing capacity of erythrocytes in patients with severe familial hypercholesterolaemia.
    Stefanutti C; Di Giacomo S; Vivenzio A; Isacchi GC; Masella R; Caprari P; Varì R; Tarzia A; Mosiello A; Cantafora A
    Clin Sci (Lond); 2001 Feb; 100(2):191-8. PubMed ID: 11171288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term therapeutic efficacy of lipoprotein apheresis on circulating oxidative stress parameters--A comparison of two different apheresis techniques.
    Kopprasch S; Bornstein SR; Bergmann S; Graessler J; Julius U
    Atheroscler Suppl; 2015 May; 18():80-4. PubMed ID: 25936309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia.
    Napoli C; Ambrosio G; Scarpato N; Corso G; Palumbo G; D'Armiento FP; Mancini FP; Malorni A; Formisano S; Ruocco A; Calí A; Chiariello M
    Am Heart J; 1997 May; 133(5):585-95. PubMed ID: 9141382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: impact of long-term low-density lipoprotein apheresis.
    Lepage S; Nigon F; Bonnefont-Rousselot D; Assogba U; Goulinet S; Chancharme L; Delattre J; Bruckert E; Chapman MJ
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):87-103. PubMed ID: 11150388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.
    Hequet O; Le QH; Rigal D; Mekhloufi F; Jaeger S; Sassolas A; Groisne L; Moulin P
    Transfus Apher Sci; 2010 Feb; 42(1):3-10. PubMed ID: 19932056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia.
    Schamberger BM; Geiss HC; Ritter MM; Schwandt P; Parhofer KG
    J Lipid Res; 2000 May; 41(5):727-33. PubMed ID: 10787433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of autoantibodies against oxidatively modified low density lipoproteins during long-term LDL-apheresis.
    Turk Z; Mrzljak V; Turk N; Metelko Z
    Diabetes Nutr Metab; 1999 Dec; 12(6):413-7. PubMed ID: 10782563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.
    Gordon BR; Kelsey SF; Dau PC; Gotto AM; Graham K; Illingworth DR; Isaacsohn J; Jones PH; Leitman SF; Saal SD; Stein EA; Stern TN; Troendle A; Zwiener RJ
    Am J Cardiol; 1998 Feb; 81(4):407-11. PubMed ID: 9485128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [LDL oxidation in homozygous familial hypercholesterolemia: effects of selective LDL-apheresis treatment].
    Napoli C; Postiglione A; Scarpato N; Corso G; Ambrosio G; Condorelli M; Mancini M; Chiariello M
    Cardiologia; 1996 May; 41(5):435-9. PubMed ID: 8767632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein-apheresis decreases oxidized low density lipoproteins and monocyte adhesion to endothelial cells.
    Cattin L; Petrucco A; Cazzolato G; Bon GB; Borelli V; Nardon E; Zabucchi G; Fonda M; Bordin P
    ASAIO J; 1997; 43(3):209-13. PubMed ID: 9152493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability.
    Kroon AA; Demacker PN; Kleinveld HA; Stalenhoef AF
    Atherosclerosis; 1999 Nov; 147(1):105-13. PubMed ID: 10525131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of low density lipoprotein apheresis in the treatment of familial hypercholesterolemia.
    Thompson GR; Kitano Y
    Ther Apher; 1997 Feb; 1(1):13-6. PubMed ID: 10225774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.
    Koga N
    Ther Apher; 1999 May; 3(2):155-60. PubMed ID: 10341391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
    Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
    Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant defense system in familial hypercholesterolemia and the effects of lipoprotein apheresis.
    Blaha V; Blaha M; Solichová D; Krčmová LK; Lánská M; Havel E; Vyroubal P; Zadák Z; Žák P; Sobotka L
    Atheroscler Suppl; 2017 Nov; 30():159-165. PubMed ID: 29096832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different low density lipoprotein apheresis machines on brain natriuretic Peptide levels in patients with familial hypercholesterolemia.
    Moriarty P; Sosland R; Gibson C; Belmont J
    Ther Apher Dial; 2010 Feb; 14(1):74-8. PubMed ID: 20438521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of children with homozygous familial hypercholesterolemia: safety and efficacy of low-density lipoprotein apheresis.
    Uauy R; Zwiener RJ; Phillips MJ; Petruska ML; Bilheimer DW
    J Pediatr; 1992 Jun; 120(6):892-8. PubMed ID: 1593349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.